| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0b82447cc9559a3ac2237f4bb1db8b58 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 |
| filingDate |
2017-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2076f0d712402eeccc2fa343f8cbcceb |
| publicationDate |
2017-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2017143687-A1 |
| titleOfInvention |
Ppar gamma agonists for treatment of multiple sclerosis |
| abstract |
Methods of treatment of multiple sclerosis (MS) with PPARĪ³ agonists, and in particular with the compound of formula (I) known as INT131: |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10555929-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10772865-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11400072-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11253508-B2 |
| priorityDate |
2013-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |